Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer.
Saved in:
| Title: | Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer. |
|---|---|
| Authors: | Ryu, Jeongryul1 (AUTHOR), Hyung, Jaewon1,2 (AUTHOR), Han, Sangwon1 (AUTHOR) hswon87@naver.com, Jeong, Jae Ho1,2 (AUTHOR) jaeho.jeong@amc.seoul.kr, Lee, Sae Byul3 (AUTHOR), Yoo, Tae-Kyung Robyn3 (AUTHOR), Kim, Jisun3 (AUTHOR), Kim, Hee Jeong3 (AUTHOR), Chung, Il Yong3 (AUTHOR), Ko, Beom Seok3 (AUTHOR), Lee, Jong Won3 (AUTHOR), Son, Byung Ho3 (AUTHOR), Jeong, Hyehyun2 (AUTHOR), Ahn, Jin-Hee2 (AUTHOR), Jung, Kyung Hae2 (AUTHOR), Kim, Sung-Bae2 (AUTHOR), Moon, Dae Hyuk1 (AUTHOR) |
| Source: | Journal of Nuclear Medicine. Nov2024, Vol. 65 Issue 11, p1689-1694. 6p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
